Literature DB >> 10776748

Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.

D M Gibb, A Newberry, N Klein, A de Rossi, I Grosch-Woerner, A Babiker.   

Abstract

In 25 vertically HIV-infected children receiving highly-active antiretroviral therapy, a 3-log10 reduction in plasma HIV RNA load was maintained for 1 year and was associated with a doubling of the CD4-cell percentage. Most (75%) new CD4 cells carried the CD45RA marker of naive cells and there was only a small rise in memory cells (CD45RO). This pattern of immune restoration differs from adults, and may be due to the presence of a functioning thymus in children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10776748     DOI: 10.1016/s0140-6736(00)02117-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.

Authors:  Akihiko Saitoh; Kumud K Singh; Sharsti Sandall; Christine A Powell; Terrence Fenton; Courtney V Fletcher; Karen Hsia; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

Review 2.  Immunization of HIV infected children.

Authors:  Jagdish Chandra; Dinesh Yadav
Journal:  Indian J Pediatr       Date:  2012-02-10       Impact factor: 1.967

Review 3.  Management of gastrointestinal disorders in children with HIV infection.

Authors:  Alfredo Guarino; Eugenia Bruzzese; Giulio De Marco; Vittoria Buccigrossi
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial.

Authors: 
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

5.  Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.

Authors:  Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

6.  Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

Authors:  Sophie Desmonde; Fatoumata Dicko; Fla Koueta; Tanoh Eboua; Eric Balestre; Clarisse Amani-Bosse; Edmond A Aka; Koko Lawson-Evi; Madeleine Amorissani-Folquet; Kouadio Kouakou; Siriatou Koumakpai; Lorna Renner; Haby Signaté Sy; Valériane Leroy
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

7.  Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.

Authors:  A Anselmi; D Vendrame; O Rampon; C Giaquinto; M Zanchetta; A De Rossi
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

8.  Supranormal thymic output up to 2 decades after HIV-1 infection.

Authors:  Christian R Aguilera-Sandoval; Otto O Yang; Nebojsa Jojic; Pietro Lovato; Diana Y Chen; Maria Ines Boechat; Paige Cooper; Jun Zuo; Christina Ramirez; Marvin Belzer; Joseph A Church; Paul Krogstad
Journal:  AIDS       Date:  2016-03-13       Impact factor: 4.177

9.  Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy.

Authors:  Adriana Weinberg; Gregory B Pott
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.

Authors:  Florin Tuluc; Sergei Spitsin; Nancy B Tustin; Jennifer B Murray; Richard Tustin; Laura A Schankel; Andrew Wiznia; Sharon Nachman; Steven D Douglas
Journal:  AIDS Res Hum Retroviruses       Date:  2016-10-18       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.